New research highlighted how immune dysregulation in adolescents with perinatally acquired HIV may contribute to cardiovascular disease risk, focusing on NK-cell dysfunction as a driver. The study underscores why cardiovascular monitoring and immunology-informed risk stratification may be especially important as long-term outcomes improve with modern antiretroviral therapy.